- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- hetero-oligomer
- Ligands
- 12 x FE: FE (III) ION(Non-covalent)
- 36 x CYN: CYANIDE ION(Non-covalent)
CYN.2: 8 residues within 4Å:- Chain B: Y.109, R.158, H.161, H.163, Q.178
- Ligands: FE.1, CYN.3, CYN.4
Ligand excluded by PLIPCYN.3: 8 residues within 4Å:- Chain B: Y.109, Y.148, R.158, H.161, H.163
- Ligands: FE.1, CYN.2, CYN.4
Ligand excluded by PLIPCYN.4: 8 residues within 4Å:- Chain A: G.18, P.19, Y.20
- Chain B: Y.109, H.163
- Ligands: FE.1, CYN.2, CYN.3
Ligand excluded by PLIPCYN.6: 8 residues within 4Å:- Chain D: Y.109, R.158, H.161, H.163, Q.178
- Ligands: FE.5, CYN.7, CYN.8
Ligand excluded by PLIPCYN.7: 8 residues within 4Å:- Chain D: Y.109, Y.148, R.158, H.161, H.163
- Ligands: FE.5, CYN.6, CYN.8
Ligand excluded by PLIPCYN.8: 8 residues within 4Å:- Chain C: G.18, P.19, Y.20
- Chain D: Y.109, H.163
- Ligands: FE.5, CYN.6, CYN.7
Ligand excluded by PLIPCYN.10: 8 residues within 4Å:- Chain F: Y.109, R.158, H.161, H.163, Q.178
- Ligands: FE.9, CYN.11, CYN.12
Ligand excluded by PLIPCYN.11: 8 residues within 4Å:- Chain F: Y.109, Y.148, R.158, H.161, H.163
- Ligands: FE.9, CYN.10, CYN.12
Ligand excluded by PLIPCYN.12: 8 residues within 4Å:- Chain E: G.18, P.19, Y.20
- Chain F: Y.109, H.163
- Ligands: FE.9, CYN.10, CYN.11
Ligand excluded by PLIPCYN.14: 8 residues within 4Å:- Chain H: Y.109, R.158, H.161, H.163, Q.178
- Ligands: FE.13, CYN.15, CYN.16
Ligand excluded by PLIPCYN.15: 8 residues within 4Å:- Chain H: Y.109, Y.148, R.158, H.161, H.163
- Ligands: FE.13, CYN.14, CYN.16
Ligand excluded by PLIPCYN.16: 8 residues within 4Å:- Chain G: G.18, P.19, Y.20
- Chain H: Y.109, H.163
- Ligands: FE.13, CYN.14, CYN.15
Ligand excluded by PLIPCYN.18: 8 residues within 4Å:- Chain J: Y.109, R.158, H.161, H.163, Q.178
- Ligands: FE.17, CYN.19, CYN.20
Ligand excluded by PLIPCYN.19: 8 residues within 4Å:- Chain J: Y.109, Y.148, R.158, H.161, H.163
- Ligands: FE.17, CYN.18, CYN.20
Ligand excluded by PLIPCYN.20: 8 residues within 4Å:- Chain I: G.18, P.19, Y.20
- Chain J: Y.109, H.163
- Ligands: FE.17, CYN.18, CYN.19
Ligand excluded by PLIPCYN.22: 8 residues within 4Å:- Chain L: Y.109, R.158, H.161, H.163, Q.178
- Ligands: FE.21, CYN.23, CYN.24
Ligand excluded by PLIPCYN.23: 8 residues within 4Å:- Chain L: Y.109, Y.148, R.158, H.161, H.163
- Ligands: FE.21, CYN.22, CYN.24
Ligand excluded by PLIPCYN.24: 8 residues within 4Å:- Chain K: G.18, P.19, Y.20
- Chain L: Y.109, H.163
- Ligands: FE.21, CYN.22, CYN.23
Ligand excluded by PLIPCYN.26: 8 residues within 4Å:- Chain N: Y.109, R.158, H.161, H.163, Q.178
- Ligands: FE.25, CYN.27, CYN.28
Ligand excluded by PLIPCYN.27: 8 residues within 4Å:- Chain N: Y.109, Y.148, R.158, H.161, H.163
- Ligands: FE.25, CYN.26, CYN.28
Ligand excluded by PLIPCYN.28: 8 residues within 4Å:- Chain M: G.18, P.19, Y.20
- Chain N: Y.109, H.163
- Ligands: FE.25, CYN.26, CYN.27
Ligand excluded by PLIPCYN.30: 8 residues within 4Å:- Chain P: Y.109, R.158, H.161, H.163, Q.178
- Ligands: FE.29, CYN.31, CYN.32
Ligand excluded by PLIPCYN.31: 8 residues within 4Å:- Chain P: Y.109, Y.148, R.158, H.161, H.163
- Ligands: FE.29, CYN.30, CYN.32
Ligand excluded by PLIPCYN.32: 8 residues within 4Å:- Chain O: G.18, P.19, Y.20
- Chain P: Y.109, H.163
- Ligands: FE.29, CYN.30, CYN.31
Ligand excluded by PLIPCYN.34: 8 residues within 4Å:- Chain R: Y.109, R.158, H.161, H.163, Q.178
- Ligands: FE.33, CYN.35, CYN.36
Ligand excluded by PLIPCYN.35: 8 residues within 4Å:- Chain R: Y.109, Y.148, R.158, H.161, H.163
- Ligands: FE.33, CYN.34, CYN.36
Ligand excluded by PLIPCYN.36: 8 residues within 4Å:- Chain Q: G.18, P.19, Y.20
- Chain R: Y.109, H.163
- Ligands: FE.33, CYN.34, CYN.35
Ligand excluded by PLIPCYN.38: 8 residues within 4Å:- Chain T: Y.109, R.158, H.161, H.163, Q.178
- Ligands: FE.37, CYN.39, CYN.40
Ligand excluded by PLIPCYN.39: 8 residues within 4Å:- Chain T: Y.109, Y.148, R.158, H.161, H.163
- Ligands: FE.37, CYN.38, CYN.40
Ligand excluded by PLIPCYN.40: 8 residues within 4Å:- Chain S: G.18, P.19, Y.20
- Chain T: Y.109, H.163
- Ligands: FE.37, CYN.38, CYN.39
Ligand excluded by PLIPCYN.42: 8 residues within 4Å:- Chain V: Y.109, R.158, H.161, H.163, Q.178
- Ligands: FE.41, CYN.43, CYN.44
Ligand excluded by PLIPCYN.43: 8 residues within 4Å:- Chain V: Y.109, Y.148, R.158, H.161, H.163
- Ligands: FE.41, CYN.42, CYN.44
Ligand excluded by PLIPCYN.44: 8 residues within 4Å:- Chain U: G.18, P.19, Y.20
- Chain V: Y.109, H.163
- Ligands: FE.41, CYN.42, CYN.43
Ligand excluded by PLIPCYN.46: 8 residues within 4Å:- Chain X: Y.109, R.158, H.161, H.163, Q.178
- Ligands: FE.45, CYN.47, CYN.48
Ligand excluded by PLIPCYN.47: 8 residues within 4Å:- Chain X: Y.109, Y.148, R.158, H.161, H.163
- Ligands: FE.45, CYN.46, CYN.48
Ligand excluded by PLIPCYN.48: 8 residues within 4Å:- Chain W: G.18, P.19, Y.20
- Chain X: Y.109, H.163
- Ligands: FE.45, CYN.46, CYN.47
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vetting, M.W. et al., Structure of Acinetobacter strain ADP1 protocatechuate 3, 4-dioxygenase at 2.2 A resolution: implications for the mechanism of an intradiol dioxygenase. Biochemistry (2000)
- Release Date
- 2000-08-09
- Peptides
- PROTOCATECHUATE 3,4-DIOXYGENASE ALPHA CHAIN: ACEGIKMOQSUW
PROTOCATECHUATE 3,4-DIOXYGENASE BETA CHAIN: BDFHJLNPRTVX - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AI
AK
AM
AO
AQ
AS
AU
AW
AB
BD
BF
BH
BJ
BL
BN
BP
BR
BT
BV
BX
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- hetero-oligomer
- Ligands
- 12 x FE: FE (III) ION(Non-covalent)
- 36 x CYN: CYANIDE ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vetting, M.W. et al., Structure of Acinetobacter strain ADP1 protocatechuate 3, 4-dioxygenase at 2.2 A resolution: implications for the mechanism of an intradiol dioxygenase. Biochemistry (2000)
- Release Date
- 2000-08-09
- Peptides
- PROTOCATECHUATE 3,4-DIOXYGENASE ALPHA CHAIN: ACEGIKMOQSUW
PROTOCATECHUATE 3,4-DIOXYGENASE BETA CHAIN: BDFHJLNPRTVX - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AI
AK
AM
AO
AQ
AS
AU
AW
AB
BD
BF
BH
BJ
BL
BN
BP
BR
BT
BV
BX
B